G2/M arrest was described in FA HSCs after in vitro DNA-crosslinker treatment, suggesting intact cell cycle checkpoints under this condition, although other studies indicate the G2/M checkpoint is impaired in FA, or requires Tp53 for activation (11, 12, 13). This evidence concerns the gene TP53 and Friedreich ataxia.